These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Thalamic and Cerebellar Regional Involvement across the ALS-FTD Spectrum and the Effect of Bocchetta M; Todd EG; Tse NY; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Piguet O; Kiernan MC; Rohrer JD; Ahmed RM Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326292 [TBL] [Abstract][Full Text] [Related]
84. Tackling clinical heterogeneity across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum using a transdiagnostic approach. Ahmed RM; Bocchetta M; Todd EG; Tse NY; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Kiernan MC; Piguet O; Rohrer JD Brain Commun; 2021; 3(4):fcab257. PubMed ID: 34805999 [TBL] [Abstract][Full Text] [Related]
85. Systematic Review: Genetic, Neuroimaging, and Fluids Biomarkers for Frontotemporal Dementia Across Latin America Countries. Duran-Aniotz C; Orellana P; Leon Rodriguez T; Henriquez F; Cabello V; Aguirre-Pinto MF; Escobedo T; Takada LT; Pina-Escudero SD; Lopez O; Yokoyama JS; Ibanez A; Parra MA; Slachevsky A Front Neurol; 2021; 12():663407. PubMed ID: 34248820 [TBL] [Abstract][Full Text] [Related]
86. End Stage Clinical Features and Cause of Death of Behavioral Variant Frontotemporal Dementia and Young-Onset Alzheimer's Disease. van Engelen ME; Gossink FT; de Vijlder LS; Meursing JRA; Scheltens P; Dols A; Pijnenburg YAL J Alzheimers Dis; 2020; 77(3):1169-1180. PubMed ID: 32925036 [TBL] [Abstract][Full Text] [Related]
87. Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Hao Z; Wang R; Ren H; Wang G Neurosci Bull; 2020 Sep; 36(9):1057-1070. PubMed ID: 32860626 [TBL] [Abstract][Full Text] [Related]
88. Progress and Challenges in Frontotemporal Dementia Research: A 20-Year Review. Hodges JR; Piguet O J Alzheimers Dis; 2018; 62(3):1467-1480. PubMed ID: 29504536 [TBL] [Abstract][Full Text] [Related]
91. Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population. Umoh ME; Fournier C; Li Y; Polak M; Shaw L; Landers JE; Hu W; Gearing M; Glass JD Neurology; 2016 Sep; 87(10):1024-30. PubMed ID: 27488601 [TBL] [Abstract][Full Text] [Related]
92. ALS and FTD: an epigenetic perspective. Belzil VV; Katzman RB; Petrucelli L Acta Neuropathol; 2016 Oct; 132(4):487-502. PubMed ID: 27282474 [TBL] [Abstract][Full Text] [Related]
93. The phenotypic variability of amyotrophic lateral sclerosis. Swinnen B; Robberecht W Nat Rev Neurol; 2014 Nov; 10(11):661-70. PubMed ID: 25311585 [TBL] [Abstract][Full Text] [Related]
94. Neural substrates of episodic memory dysfunction in behavioural variant frontotemporal dementia with and without C9ORF72 expansions. Irish M; Devenney E; Wong S; Dobson-Stone C; Kwok JB; Piguet O; Hodges JR; Hornberger M Neuroimage Clin; 2013; 2():836-43. PubMed ID: 24179835 [TBL] [Abstract][Full Text] [Related]
95. Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72. Murray ME; Bieniek KF; Banks Greenberg M; DeJesus-Hernandez M; Rutherford NJ; van Blitterswijk M; Niemantsverdriet E; Ash PE; Gendron TF; Kouri N; Baker M; Goodman IJ; Petrucelli L; Rademakers R; Dickson DW Acta Neuropathol; 2013 Oct; 126(4):545-54. PubMed ID: 23922030 [TBL] [Abstract][Full Text] [Related]